BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9648562)

  • 1. Translocation (3;21;8)(q21;q22;q22) in a patient with acute myeloid leukemia. A case report and review of prognostic indicators.
    Giles FJ; Kanemaki TJ; Schreck RR; Qasabian L; Fuerst MP; Lim SW
    Cancer Genet Cytogenet; 1998 Jul; 104(1):66-9. PubMed ID: 9648562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
    Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22).
    Bacher U; Schnittger S; Kern W; Trenn G; Weisser M; Haferlach T; Schoch C
    Cancer Genet Cytogenet; 2006 Jul; 168(2):172-4. PubMed ID: 16843110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia with new complex t(8;21;22) induced hemophagocytic lymphohistiocytosis: A case report.
    Wu Y; Xu J; Shen K; Ji J; Yang C; Liu T; Xiang B
    Medicine (Baltimore); 2018 Nov; 97(44):e12762. PubMed ID: 30383631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical analysis of acute myeloid leukemia with t(8;21) (q22;q22) and loss of Y chromosome].
    Zhu CY; Yang H; Niu JH; Zhang Q; Xie XL; Wang LJ; Zhu HY; Yao ZL; Yu L; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):950-6. PubMed ID: 25130809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia with a RUNX1-RUNX1T1 t(1;21;8)(q21;q22;q22) novel variant: a case report and review of the literature.
    Kim H; Moon HW; Hur M; Yun YM; Lee MH
    Acta Haematol; 2011; 125(4):237-41. PubMed ID: 21325813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis and treatment outcome in patients with acute myeloid leukemia with t(8;21)(q22;q22).
    Chen CC; Gau JP; Yu YB; Lu CH; Lee KD; You JY
    Adv Ther; 2007; 24(4):907-20. PubMed ID: 17901040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo acute myelogenous leukemia with trilineage myelodysplasia associated with t(8;21)(q22;q22).
    Fujisawa S; Togawa J; Tanaka M; Koharazawa H; Aoba M; Fujita H; Murata T; Kanamori H; Matsuzaki M; Mohri H; Ishigatsubo Y
    Intern Med; 1999 Jul; 38(7):607-11. PubMed ID: 10435370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heterogeneity of acute myeloid leukemia with the translocation t(8;21)(q22;q22)].
    Gritsaev SV; Martynkevich IS; Ziuzgin IS; Kariagina EV; Martynenko LS; Petrova EV; Tsybakova NIu; Ivanova MP; Kostroma II; Tiranova SA; Potikhonova NA; Abdulkadyrov KM
    Ter Arkh; 2014; 86(7):45-52. PubMed ID: 25314777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of minimal residual disease in a patient having acute myelogenous leukemia with t(16;21)(p11;q22) treated by allogeneic bone marrow transplantation.
    Okoshi Y; Shimizu S; Kojima H; Obara N; Mukai HY; Komeno T; Hasegawa Y; Mori N; Nagasawa T
    Acta Haematol; 2001; 105(1):45-8. PubMed ID: 11340253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unusual three-way translocation t(21;8;1)(q22;q22;q32) in a case of acute myeloid leukemia (M2).
    Gmidène A; Sennana H; Frikha R; Elloumi M; Belaaj H; Saad A
    Ann Biol Clin (Paris); 2012; 70(2):213-6. PubMed ID: 22484534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor outcome in a pediatric patient with acute myeloid leukemia associated with a variant t(8;21) and trisomy 6.
    Kelly MJ; Meloni-Ehrig AM; Manley PE; Altura RA
    Cancer Genet Cytogenet; 2009 Feb; 189(1):48-52. PubMed ID: 19167612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and clinical advances in core binding factor primary acute myeloid leukemia: a paradigm for translational research in malignant hematology.
    Marcucci G; Caligiuri MA; Bloomfield CD
    Cancer Invest; 2000; 18(8):768-80. PubMed ID: 11107447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
    Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
    J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy-related acute myeloid leukemia with t(8;21) (q22;q22) shares many features with de novo acute myeloid leukemia with t(8;21)(q22;q22) but does not have a favorable outcome.
    Gustafson SA; Lin P; Chen SS; Chen L; Abruzzo LV; Luthra R; Medeiros LJ; Wang SA
    Am J Clin Pathol; 2009 May; 131(5):647-55. PubMed ID: 19369623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal selection of CD56+ t(8;21) AML blasts: further suggestion of the adverse clinical significance of this biological marker?
    Daniels JT; Davis BJ; Houde-McGrail L; Byrd JC
    Br J Haematol; 1999 Nov; 107(2):381-3. PubMed ID: 10583228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. t(8;21) (q22;q22) acute myelogenous leukemia in Mexico: a single institution experience.
    Ruiz-Argüelles GJ; Morales-Toquero A; Manzano C; Ruiz-Delgado GJ; Jaramillo P; Gonzalez-Carrillo ML; Reyes-Núñez V
    Hematology; 2006 Aug; 11(4):235-8. PubMed ID: 17178661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21).
    Iriyama N; Hatta Y; Takeuchi J; Ogawa Y; Ohtake S; Sakura T; Mitani K; Ishida F; Takahashi M; Maeda T; Izumi T; Sakamaki H; Miyawaki S; Honda S; Miyazaki Y; Taki T; Taniwaki M; Naoe T
    Leuk Res; 2013 Sep; 37(9):1021-6. PubMed ID: 23810283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duplication 15q in a patient with t(8;21) acute myeloblastic leukemia (M2).
    Zhang L; Mulvihill JJ; Kinasewitz GT; Scott KV; Bates F; Li S
    Cancer Genet Cytogenet; 2002 Mar; 133(2):148-51. PubMed ID: 11943342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.